Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Sep 7;133(35):13934-7.
doi: 10.1021/ja206469q. Epub 2011 Aug 15.

Intermolecular alignment in Y145Stop human prion protein amyloid fibrils probed by solid-state NMR spectroscopy

Affiliations

Intermolecular alignment in Y145Stop human prion protein amyloid fibrils probed by solid-state NMR spectroscopy

Jonathan J Helmus et al. J Am Chem Soc. .

Abstract

The Y145Stop mutant of human prion protein, huPrP23-144, has been linked to PrP cerebral amyloid angiopathy, an inherited amyloid disease, and also serves as a valuable in vitro model for investigating the molecular basis of amyloid strains. Prior studies of huPrP23-144 amyloid by magic-angle-spinning (MAS) solid-state NMR spectroscopy revealed a compact β-rich amyloid core region near the C-terminus and an unstructured N-terminal domain. Here, with the focus on understanding the higher-order architecture of huPrP23-144 fibrils, we probed the intermolecular alignment of β-strands within the amyloid core using MAS NMR techniques and fibrils formed from equimolar mixtures of (15)N-labeled protein and (13)C-huPrP23-144 prepared with [1,3-(13)C(2)] or [2-(13)C]glycerol. Numerous intermolecular correlations involving backbone atoms observed in 2D (15)N-(13)C spectra unequivocally suggest an overall parallel in-register alignment of the β-sheet core. Additional experiments that report on intermolecular (15)N-(13)CO and (15)N-(13)Cα dipolar couplings yielded an estimated strand spacing that is within ∼10% of the distances of 4.7-4.8 Å typical for parallel β-sheets.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(A) Partial amino acid sequence of huPrP23-144. Residues exhibiting significant conformational dynamics are shown in red font, and relatively rigid amyloid core residues are shown in black font, with the three β-strand segments predicted using TALOS+ highlighted by gray rectangles. Also shown is a summary of the intermolecular 15N-13C correlations observed in z-filtered TEDOR spectra recorded for the mixed 1,3-13C/15N- and 2-13C/15N huPrP23-144 fibril samples (panels (D) and (G) and panel (C) of Figure S1). Thick green rectangles under residue i indicate than an unambiguous intermolecular 15N-13C correlation was observed between the amide 15N of residue i and 13COi-1 and/or 13COi (NCO), 13i-1 and/or 13i (NCA), and side-chain 13C of residue i (NCX). Narrow green rectangles correspond to ambiguous intermolecular 15N-13C correlations. (B–D) 15N-13CO (NCO) correlation spectra of huPrP23-144 amyloid fibrils recorded at 500 MHz 1H frequency, 11.111 kHz MAS rate and effective sample temperature of ~5 °C using the z-filtered TEDOR pulse scheme with 15N-13C dipolar mixing times, τTEDOR, indicated in the spectra. The fibril samples were prepared from (B) 1,3-13C,15N-huPrP23-144, (C) a mixture of 1,3-13C,15N-huPrP23-144 and natural abundance (12C,14N) huPrP23-144 in a 1:3 molar ratio, and (D) a mixture of 1,3-13C-huPrP23-144 and 15N-huPrP23-144 in a 1:1 molar ratio. The experiment times for spectra in panels (B–D) were ~14, ~27 and ~212 h, respectively. (E–G) Similar to panels (B–D), but for 15N-13Cα (NCA) spectra and fibril samples grown from huPrP23-144 prepared using [2-13C] instead of [1,3-13C]glycerol. The experiment times were ~7, ~27 and ~216 h, respectively.
Figure 2
Figure 2
Experimental (points) and simulated (lines) 1D TEDOR trajectories that report simultaneously on all intermolecular (A) 15N-13CO and (C) 15N-13Cα distances in huPrP23-144 amyloid fibrils. Experimental trajectories in panels (A) and (C) were recorded for the mixed 1,3-13C/15N and 2-13C/15N fibril samples, respectively, as described in the Supporting Information and the 13CO and 13Cα intensities in the plots are scaled by corresponding intensities in CP 13C reference spectra recorded under identical conditions. The total experiment times were ~41 h and ~68 h, respectively. (B, D) Model spin systems, based on the X-ray structure of amyloid-like microcrystals of the peptide GNNQQNY displaying a parallel in-register alignment of the β-strands (PDB ID 2OMM), used to generate the simulated TEDOR trajectories corresponding to experimental data in panels (A) and (C), respectively, within the SPINEVOLUTION software, with the atoms included in the simulations indicated by spheres. The simulated trajectories were generated as described in detail in the Supporting Information, as a function of a single distance parameter, d, corresponding to the spacing (in Å) between adjacent β-strands as indicated in the structural models. The best-fit 15N-13CO and 15N-13Cα simulations, corresponding to d = 4.4 Å, are shown as solid lines and simulations for d values of ±10% from the best-fit are shown as dashed lines.

Similar articles

Cited by

References

    1. Prusiner SB. Proc. Natl. Acad. Sci. USA. 1998;95:13363–13383. - PMC - PubMed
    2. Caughey B, Chesebro B. Adv. Virus Res. 2001;56:277–311. - PubMed
    3. Collinge J. Annu. Rev. Neurosci. 2001;24:519–550. - PubMed
    1. Legname G, Baskakov IV, Nguyen HO, Riesner D, Cohen FE, DeArmond SJ, Prusiner SB. Science. 2004;305:673–676. - PubMed
    2. Deleault NR, Harris BT, Rees JR, Supattapone S. Proc. Natl. Acad. Sci. USA. 2007;104:9741–9746. - PMC - PubMed
    3. Wang F, Wang X, Yuan CG, Ma J. Science. 2010;327:1132–1135. - PMC - PubMed
    4. Kim JI, Cali I, Surewicz K, Kong Q, Raymond GJ, Atarashi R, Race B, Qing L, Gambetti P, Caughey B, Surewicz WK. J. Biol. Chem. 2010;285:14083–14087. - PMC - PubMed
    1. Chien P, Weissman JS, DePace AH. Annu. Rev. Biochem. 2004;73:617–656. - PubMed
    2. Wickner RB, Edskes HK, Roberts BT, Baxa U, Pierce MM, Ross ED, Brachmann A. Genes Dev. 2004;18:470–485. - PubMed
    1. Collinge J, Clarke AR. Science. 2007;318:930–936. - PubMed
    2. Aguzzi A, Sigurdson C, Heikenwaelder M. Annu. Rev. Pathol. 2008;3:11–40. - PubMed
    3. Cobb NJ, Surewicz WK. Biochemistry. 2009;48:2574–2585. - PMC - PubMed
    1. Ghetti B, Tagliavini F, Takao M, Bugiani O, Piccardo P. Clin. Lab. Med. 2003;23:65–85. - PubMed

Publication types